The pharmacogenetics of tacrolimus and its implications for personalized therapy in kidney transplant recipients

Francke, Marith I.; de Winter, Brenda C.M.; Elens, Laure; Lloberas, Nuria; Hesselink, Dennis A.

doi:10.1080/23808993.2020.1776107

The pharmacogenetics of tacrolimus and its implications for personalized therapy in kidney transplant recipients

Francke, Marith I.

;

de Winter, Brenda C.M.

;

Elens, Laure

;

Lloberas, Nuria

;

Hesselink, Dennis A.

(2020) Expert Review of Precision Medicine and Drug Development — Vol. 5, n° 5, p. 313-316 (2020)

Files

Thepharmacogeneticsoftacrolimusanditsimplicationsforpersonalizedtherapyinkidneytransplantrecipients1.pdf

Open Access
Adobe PDF
517.58 KB

Download

Details

Authors

Francke, Marith I.
Author
de Winter, Brenda C.M.
Author
Elens, LaureUCLouvain
Author
Lloberas, Nuria
Author
Hesselink, Dennis A.
Author

Affiliations

UCLouvainSSS/LDRI - Louvain Drug Research Institute
UCLouvainSSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology

Citations

APA
Chicago
FWB

Francke, M. I., de Winter, B. C. M., Elens, L., Lloberas, N., & Hesselink, D. A. (2020). The pharmacogenetics of tacrolimus and its implications for personalized therapy in kidney transplant recipients. Expert Review of Precision Medicine and Drug Development, 5(5), 313-316. https://doi.org/10.1080/23808993.2020.1776107 (Original work published 2020)